Back to Search
Start Over
A novel sequencing-based vaginal health assay combining self-sampling, HPV detection and genotyping, STI detection, and vaginal microbiome analysis
- Source :
- PLoS ONE, Vol 14, Iss 5, p e0215945 (2019), PLoS ONE, CONICET Digital (CONICET), Consejo Nacional de Investigaciones Científicas y Técnicas, instacron:CONICET
- Publication Year :
- 2019
- Publisher :
- Public Library of Science (PLoS), 2019.
-
Abstract
- The composition of the vaginal microbiome, including both the presence of pathogens involved in sexually transmitted infections (STI) as well as commensal microbiota, has been shown to have important associations for a woman´s reproductive and general health. Currently, healthcare providers cannot offer comprehensive vaginal microbiome screening, but are limited to the detection of individual pathogens, such as high-risk human papillomavirus (hrHPV), the predominant cause of cervical cancer. There is no single test on the market that combines HPV, STI, and microbiome screening. Here, we describe a novel inclusive vaginal health assay that combines self-sampling with sequencing-based HPV detection and genotyping, vaginal microbiome analysis, and STI-associated pathogen detection. The assay includes genotyping and detection of 14 hrHPV types, 5 low-risk HPV types (lrHPV), as well as the relative abundance of 31 bacterial taxa of clinical importance, including Lactobacillus, Sneathia, Gardnerella, and 3 pathogens involved in STI, with high sensitivity, specificity, and reproducibility. For each of these taxa, reference ranges were determined in a group of 50 self-reported healthy women. The HPV sequencing portion of the test was evaluated against the digene High-Risk HPV HC2 DNA test. For hrHPV genotyping, agreement was 95.3% with a kappa of 0.804 (601 samples); after removal of samples in which the digene hrHPV probe showed cross-reactivity with lrHPV types, the sensitivity and specificity of the hrHPV genotyping assay were 94.5% and 96.6%, respectively, with a kappa of 0.841. For lrHPV genotyping, agreement was 93.9% with a kappa of 0.788 (148 samples), while sensitivity and specificity were 100% and 92.9%, respectively. This novel assay could be used to complement conventional cervical cancer screening, because its self-sampling format can expand access among women who would otherwise not participate, and because of its additional information about the composition of the vaginal microbiome and the presence of pathogens. Fil: Bik, Elisabeth M.. Ubiome; Fil: Bird, Sara W.. Ubiome; Fil: Bustamante, Juan Pablo. Universidad Nacional de Entre Ríos. Instituto de Investigación y Desarrollo en Bioingeniería y Bioinformática - Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe. Instituto de Investigación y Desarrollo en Bioingeniería y Bioinformática; Argentina Fil: Leon, Luis E.. Ubiome
- Subjects :
- 0301 basic medicine
Gardnerella
Viral Diseases
Ciencias de la Salud
Artificial Gene Amplification and Extension
Pathology and Laboratory Medicine
Cervical Cancer
Polymerase Chain Reaction
law.invention
Limit of Detection
law
RNA, Ribosomal, 16S
Genotype
Medicine and Health Sciences
Medicine
Papillomaviridae
DNA extraction
Polymerase chain reaction
Cervical cancer
Multidisciplinary
Microbiota
Gene Pool
Genomics
Middle Aged
Otras Ciencias de la Salud
Infectious Diseases
Oncology
Medical Microbiology
Viral Pathogens
Vagina
Viruses
purl.org/becyt/ford/3 [https]
Female
Pathogens
Research Article
Adult
Human Papillomavirus Infection
Genotyping
CIENCIAS MÉDICAS Y DE LA SALUD
Adolescent
Papillomaviruses
Urology
Science
030106 microbiology
Sexually Transmitted Diseases
VAGINAL MICROBIOME ANALYSIS
Microbial Genomics
Hpv detection
Sensitivity and Specificity
Microbiology
purl.org/becyt/ford/3.3 [https]
Young Adult
03 medical and health sciences
Extraction techniques
Genetics
Humans
Microbiome
Molecular Biology Techniques
Microbial Pathogens
Molecular Biology
Evolutionary Biology
Biology and life sciences
Population Biology
Genitourinary Infections
business.industry
Papillomavirus Infections
Organisms
Reproducibility of Results
Human Papillomavirus
Cancers and Neoplasms
Oncogene Proteins, Viral
medicine.disease
Virology
Research and analysis methods
Lactobacillus
MICROBIOME
030104 developmental biology
HPV DETECTION
DNA, Viral
Capsid Proteins
DNA viruses
business
Gynecological Tumors
Population Genetics
Kappa
VAGINAL HEALTH ASSAY
Subjects
Details
- ISSN :
- 19326203
- Volume :
- 14
- Database :
- OpenAIRE
- Journal :
- PLOS ONE
- Accession number :
- edsair.doi.dedup.....77ef7d3814522f61adbcbab0a3bbc67f
- Full Text :
- https://doi.org/10.1371/journal.pone.0215945